Endermotherapy With Burn Hypertrophic Scars

NCT ID: NCT03697447

Last Updated: 2024-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

19 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-13

Study Completion Date

2020-02-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mechanical massage or endermotherapyTM is applied to scar tissue with the intended therapeutic value being the promotion of structural or physiological changes. These proposed changes are meant to induce more pliability, so that skin possesses the strength and elasticity required for normal mobility. The advantage of mechanical massage compared to manual massage is that it provides a standard dosage using rollers and suction valves to mobilize the tissue. However, research documenting and supporting this effect is lacking. The objective of this proposal is to document the effect of 12 weeks of endermotherapy treatment on hypertrophic scar characteristics, including erythema, pigmentation, pliability, and thickness in adult burn survivors and their subjective evaluation of itch, pain and overall scar outcome through a prospective, randomized, controlled, within-patient, single-blinded study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will receive 12 weeks of endermotherapy , 3 times a week.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Burn Scar

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endermotherapy treated scar

Endermotherapy massage treatment

Group Type EXPERIMENTAL

Endermotherapy

Intervention Type PROCEDURE

Endermotherapy massage (mechanic massage) of burn scar

Control scar

No intervention, standard of care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endermotherapy

Endermotherapy massage (mechanic massage) of burn scar

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* females and males, of any race, 14 years or older,
* a thermal injury,
* at least 3 months post-burn so that the scars will be durable enough to tolerate the proposed forces,
* at least 2 scar sites \>2.034 mm thick and within 0.5 mm of each other, and
* signed the informed patient consent form

Exclusion Criteria

* subjects who have keloids,
* with a diagnosis of psychiatric illness clearly documented in their medical file,
* mechanism of injury is an electrical, chemical, or cold injury,
* a dermatological conditions in the region of the evaluation site, that may interfere with the study results,
* a suspected or known allergy to ultrasound gel,
* unable to understand French or English, or
* subjects who refuse to give informed consent.
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bernadette Nedelec, PhD

Role: PRINCIPAL_INVESTIGATOR

CRCHUM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Montreal Burn Unit

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15.374

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Cryotherpy on Hypertrophic Scar
NCT04532840 UNKNOWN PHASE2/PHASE3